Try our Advanced Search for more refined results
Intellectual Property UK
-
March 31, 2025
Nokia, Amazon End Long-Running Patent Feud With License
Nokia said Monday that it has inked a patent agreement with Amazon to cover its video technology, marking the end of litigation between the two companies across several continents.
-
March 28, 2025
Patent Court Likely To Lure Patent Holders With UK IP In Play
The Unified Patent Court has now doubled down on its authority to hear claims involving U.K. patents, a move that is likely to make the court an even more desirable forum for global infringement actions.
-
March 28, 2025
VistaJet Escapes VC Fund's Claim Over Investment Deal
A private jet company owner escaped allegations from a Guernsey venture capital fund that he secretly set up companies to leverage the resources of a business it had invested in, when a London court ruled Friday that the claim came too late.
-
March 28, 2025
UK Litigation Roundup: Here's What You Missed In London
This past week in London has seen sparkling winemaker Nyetimber hit a rival distillery with an intellectual property claim, Newcastle United's former owner Mike Ashley target the club's ex-vice president for damages tied to a fraudulent investment, and a real estate agency file a legal claim against law firm Winston & Strawn LLP. Here, Law360 looks at these and other new claims in the U.K.
-
March 28, 2025
CureVac RNA Vax Patent Survives BioNTech's EU Challenge
CureVac SE has fended off a challenge from BioNTech SE of its mRNA therapy patent at a European patent authority, paving the way for CureVac to forge ahead with litigation in the companies' home country of Germany accusing BioNTech of infringing its invention.
-
March 28, 2025
Pharma Co. Sues Ex-VP For Trade Theft To Benefit Rival
A pharma company has sued its former senior vice president, accusing him of secretly downloading confidential information in order to share it with a rival weeks before he resigned.
-
March 28, 2025
MSD Loses Appeal Over Ruling It Broke 'Merck' Branding Ban
A London appeals court upheld on Friday a ruling that U.S.-based Merck Sharp & Dohme LLC breached a court order blocking its use of the name "Merck" in a move to safeguard German rival Merck KGaA's trademark rights.
-
March 28, 2025
AstraZeneca Can't Stop Generic Diabetes Drug Launch
AstraZeneca has lost an attempt to prevent pharmaceutical company Glenmark from launching a generic version of its $1 billion diabetes drug Forxiga, as a London court refused on Friday to stop the generic maker before a decision on whether AstraZeneca's patent is valid.
-
March 27, 2025
AstraZeneca Fights Generic Diabetes Drug Launch
AstraZeneca on Thursday asked a London court to block pharmaceutical company Glenmark from launching a generic version of the drug giant's $1 billion Type 2 diabetes treatment Forxiga, ahead of a decision on whether AstraZeneca's patent is valid.
-
March 27, 2025
Warner Bros 'Multiversus' UK TM Gets Green Light
Warner Bros. can register a trademark for its online multiplayer game Multiversus, after British officials ruled that gamers would think it was entirely disconnected from a rival firm's "Versus" brand.
-
March 27, 2025
Parties Can Dodge Costs By Surrendering Patents, UPC Says
Parties facing challenges to their patents can swerve liability for their opponent's costs by giving up their intellectual property protections at the outset of the dispute, an appeals panel at the Unified Patent Court has ruled.
-
March 27, 2025
Beverage Biz Can't Corner The Market For 'Norwich City' TM
U.K. trademark officials have chucked a drinks maker's bid for a "Norwich City" trademark for alcoholic drinks, rejecting the company's argument that it should be allowed because the city's football club already owns a trademark for "Norwich City FC."
-
March 27, 2025
Top EU Court Urged To Uphold €60M Teva Pay-For-Delay Fine
An adviser to the European Union's top court said Thursday that it should uphold €60.5 million ($70.7 million) in fines against Teva and its subsidiary Cephalon for an alleged conspiracy to keep a generic version of Provigil off the shelves.
-
March 27, 2025
Unitary Patent Uptake 'Surpassing Expectations,' EPO Says
The European Patent Office has said it received more than 28,000 requests for unitary protection in its second year as more than a quarter of applicants sought to protect their inventions under the new framework.
-
March 26, 2025
Claims Firm Beats Whistleblower's Fraud Case
A claims manager didn't blow the whistle on forged signatures at an insurance claims handler because he had waited until his resignation day to alert senior management, an employment tribunal has ruled.
-
March 26, 2025
Software Developer Loses 'Baidu' TM On Appeal
A Dutch provider of software for TV channels has lost its rights to use "Baidu" as a trademark, after a European court found that it hadn't used the name to market goods and services it had applied for.
-
March 26, 2025
Bacardi Halts Counterfeit Grey Goose Bottles At Dutch Court
Bacardi has convinced a Dutch court to bar a Hong Kong drinks trader from selling counterfeit Grey Goose vodka in the Netherlands, after the court found the company had infringed Bacardi's protected branding.
-
March 26, 2025
Cannabis Event Biz Loses Bid For 'Cannafair' TM
A European court threw out a challenge by cannabis trade fair company Cannafair on Wednesday over the decision by European trademark officials to refuse a trademark for the name of its event, ruling that its name was a literal description of the event.
-
March 26, 2025
Lotus Biscoff Loses EU Appeal To Register Color TM
Lotus Bakeries NV has lost another bid to protect the red and white coloring of its biscuit packaging after failing to convince European officials that shoppers would immediately recognize its brand.
-
March 26, 2025
EU Court Upholds Polish Biz's Rights To Public Toilet Design
A European Union court has rejected a Polish company's latest bid to quash a rival's protections for a public toilet design, ruling Wednesday that the design was new and consequently valid.
-
March 25, 2025
Portuguese Bag Maker Can't Nix Rival 'Cavallini' TM
European officials have ruled that an Italian designer can sell leather goods and clothing using the trademark "about a boy Erika Cavallini" because shoppers would understand it wasn't related to Cavalinho-branded bags and accessories.
-
March 25, 2025
Amazon Can't Make Last-Minute Tweaks In Nokia UPC Clash
Amazon has lost its bid to file additional grounds of appeal in a patent dispute with Nokia over video-coding technology after Europe's patent court held that it wouldn't be fair to its Finnish rival.
-
March 25, 2025
Roche Voids Biogen's Protein Production Patent At EPO
The European Patent Office has stripped Biogen of its protein production patent amid Roche's protests, ruling in a decision released Tuesday that the tech lacks novelty in light of a key ruling from the agency's top appeals panel.
-
March 25, 2025
Ex-Private Equity Exec Denies Data Theft, Alleges Misconduct
A former manager at private equity firm Appian Capital Advisory LLP has denied stealing the company's data and poaching staff and clients, telling a London court the business sued him after pushing him out because he voiced concerns about his boss's misconduct.
-
March 25, 2025
Football Shirt Biz Can't Show Red Card To Rival's TM Bid
A retro football shirt retailer has lost its attempt to boot out a competitor's "Scoreline" U.K. trademark application, failing to prove that shoppers could confuse the mark with its own "Score Draw" branding.
Expert Analysis
-
The EU Design System Changes US Cos. Need To Know About
With a number of major reforms to the European Union's design protection system set to take effect in the first half of 2025, U.S. companies need to stay informed about specific details to maintain effective intellectual property management in the EU market, say lawyers at Finnegan.
-
What New Int'l Treaty Means For Global AI Regulation
Lawyers at Bird & Bird consider how global artificial intelligence regulation will be affected by the first international AI treaty recently signed by the U.S., EU and U.K., as well as its implications for business and several issues that stakeholders should be aware of.
-
HMRC Transfer Pricing Guide A Vital Resource For Businesses
HM Revenue & Customs' recent guidelines on common transfer pricing compliance risks should be required reading for affected businesses in indicating HMRC's expected benchmark for documents and policies, say Tomoko Ikawa and Kapisha Vyas at Simmons & Simmons.
-
Comparing Apples To Oranges In EPO Claim Interpretation
A referral before the Enlarged Board of Appeal could fundamentally change the role that descriptions play in claims interpretation at the European Patent Office, altering best drafting practices for patent applications construed there, say lawyers at Finnegan.
-
Why India May Become A Major Patent Litigation Forum
India is reinventing itself with the goal of becoming a global hot spot for patent litigation, with recent developments at the Delhi High Court creating incentives for plaintiffs to assert patent rights in India, say Ranganath Sudarshan at Covington and IP litigator Udit Sood.
-
Takeaways From UPC's Amgen Patent Invalidity Analysis
The Unified Patent Court Central Division's decision in Regeneron v. Amgen to revoke a patent for lack of inventive step is particularly clear in its reasoning and highlights the risks to patentees of the new court's central revocation powers, say Jane Evenson and Caitlin Heard at CMS.
-
UK Approach To AI Patentability Appears Settled For Now
After a High Court ruling upended the status quo last year, the Court of Appeal’s recent decision that Emotional Perception’s artificial neural network is not patentable represents a return to the U.K.’s familiar, albeit often complex, approach to patentability of artificial intelligence technology and computer programs generally, say lawyers at Potter Clarkson.
-
AI Reforms Prompt Fintech Compliance Considerations
With the EU Artificial Intelligence Act's Aug. 1 enforcement, and the U.K.'s new plans to introduce AI reforms, fintech companies should consider how to best focus limited resources as they balance innovation and compliance, says Nicola Kerr-Shaw at Skadden.
-
10 Ways To Manage AI Risks In Service Contracts
With the European Union Artificial Intelligence Act coming into force on Aug. 1 and introducing a new regulatory risk, and with AI technology continuing to develop at pace, parties to services arrangements should employ mechanisms now to build in flexibility and get on the front foot, says James Longster at Travers Smith.
-
What Future May Hold For AI Innovation In UK Under Labour
Labour’s recent King's Speech was notable in its absence of discussion of a comprehensive artificial intelligence bill, and while this may indicate to many that the UK is open for business, the party’s approach to cross-sectoral engagement will be critical for shaping Britain's AI landscape in the near term, says Alexander Amato-Cravero at Herbert Smith.
-
Don't Wing Settlements: Lessons From Morley's TM Ruling
In Morley's v. Sivakumar, the Intellectual Property Enterprise Court recently found that a fast-food franchiser had breached a fried chicken franchise's trademark rights, despite a prior settlement agreement, offering lessons on drafting express terms to ensure IP protection, say Nessa Khandaker and Clare Cornell at Finnegan.
-
Use Or Lose It: European TM Ruling Stresses 'Genuine Use'
The European Union General Court recently dismissed an action to revoke trademark protections for a lack of use in Sta Grupa v. EU Intellectual Property Office, offering significant insight into the intricacies of assessing evidence of genuine use in revocation actions, says Sumi Nadarajah at FRKelly.
-
1 Year At The UPC: Implications For Transatlantic Disputes
In its first year, the Unified Patent Court has issued important decisions on procedures like provisional measures, but complexities remain when it comes to coordinating proceedings across jurisdictions like the U.S. due to differences in timelines and discovery practices, say attorneys at McDermott.
-
Trends, Tips From 7 Years Of EPO Antibody Patent Appeals
Recent years of European Patent Office decisions reveal some surprising differences between appeals involving therapeutic antibody patents and those for other technologies, offering useful insight into this developing area of European case law for future antibody patent applicants, say Alex Epstein and Jane Evenson at CMS.
-
Companies Trading In The EU Should Heed Mondelēz Ruling
The European Commission’s recent €337.5 million fine of Mondelēz is the latest decision targeting restrictions on EU cross-border trade, and serves as a warning to companies active in the region to check their contracts and practices for illegal restraints, and to perform audits to ensure compliance, says Matthew Hall at McGuireWoods.